
|Articles|December 1, 2004
Accommodating lens available in 0.25-D steps
Aliso Viejo, CA-The FDA has given Eyeonics Inc. approval to market its Crystalens accommodating IOL in quarter-diopter steps. The approval makes eyeonics the first U.S. company to launch 0.25-D IOLs, the company said. The lenses were made available Nov. 1 to credentialed Crystalens surgeons.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Q&A: What changed in residency education in 2025? Perspectives from training directors
4
Achieving a new level of refractive precision: Surgical strategies
5




